Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide - Université de Lorraine
Article Dans Une Revue Clinical Gastroenterology and Hepatology Année : 2022

Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide

Résumé

Herpes zoster is a painful dermatomal cutaneous eruption resulting from reactivation of the latent varicella-zoster virus. Patients with inflammatory bowel diseases have an increased risk of shingles compared with the general population and this risk can be increased with the use of immunosuppressive therapy. Live zoster vaccine and recombinant zoster vaccine have shown efficacy for the prevention of herpes zoster. The recombinant zoster vaccine seems to offer greater efficacy and long-term protection profile compared with the life zoster vaccine. However, their use in clinical practice still is unclear and updated vaccination recommendations are lacking. This review discusses the risk for shingles in patients with inflammatory bowel diseases, available vaccines, and their efficacy and safety profiles. We also provide guidance on who, when, and how to vaccinate for herpes zoster in routine clinical practice among patients with inflammatory bowel diseases.
Fichier principal
Vignette du fichier
S1542356520314403.pdf (212.45 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04167973 , version 1 (22-07-2024)

Licence

Identifiants

Citer

Lucas Guillo, Christian Rabaud, Ernest Choy, Ferdinando D’amico, Silvio Danese, et al.. Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide. Clinical Gastroenterology and Hepatology, 2022, 20 (3), pp.481-490. ⟨10.1016/j.cgh.2020.10.027⟩. ⟨hal-04167973⟩
20 Consultations
9 Téléchargements

Altmetric

Partager

More